Human leukemia HL-60 cell drug-resistance cell line HL-60/RS cell and preparation method thereof

A technology for drug-resistant cells and leukemia, applied in biochemical equipment and methods, animal cells, tumors/cancer cells, etc., can solve the problems of arsenic sensitivity and no arsenic resistance

Inactive Publication Date: 2014-08-27
LANZHOU UNIVERSITY
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The currently commonly used leukemia multidrug-resistant cell lines induced by doxorubicin and overexpres

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human leukemia HL-60 cell drug-resistance cell line HL-60/RS cell and preparation method thereof
  • Human leukemia HL-60 cell drug-resistance cell line HL-60/RS cell and preparation method thereof
  • Human leukemia HL-60 cell drug-resistance cell line HL-60/RS cell and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Adriamycin was used as an inducer to induce HL-60 cells to establish multidrug-resistant cell lines. ① HL-60 was inoculated in RPMI 1640 culture medium containing 15% newborn bovine serum, 100 U / mL penicillin, 100 μg / mL streptomycin, placed at 37°C, 5% CO 2, in a saturated humidity incubator. ②Add doxorubicin to the cell culture system, the initial impact concentration is 0.1mg / L, and when the surviving cells return to normal growth, add the same concentration of drugs to induce, and so on, until the cells can survive and proliferate normally at this concentration , then increase the impact drug concentration, and carry out the second round of impact induction, and the drug concentration increase range is 0.1mg / L. Such repeated intermittent shock induction, and with the increase in the number of shock inductions and drug resistance, the increase in drug concentration in each round of shock is gradually increased, the initial range is small, and the amplitude in the lat...

Embodiment 2

[0046] The induction establishment method of HL-60 / RS cells is the same as that in Example 1. One month after the stable growth of HL-60 / RS cells, the sensitivity to arsenic trioxide was determined. HL-60 / RS cells (choose HL-60 sensitive cells, K562 / ADM multidrug-resistant cells and their parental K562 cells as controls), press 1.0×10 5 cells / mL inoculated in 96-well culture plate, adding 0.1-5.0mg / L As 2 o 3 , 37℃, 5%CO 2 And cultured under saturated humidity conditions for 24-72h, MTT assay cell proliferation inhibition and IC50. HL-60 / RS cells are highly resistant to arsenic trioxide, 12.89 times that of parental HL-60 cells and 10.89 times that of K562 / ADM drug-resistant cells.

Embodiment 3

[0048] The induction establishment method of HL-60 / RS cells is the same as that in Example 1. HL-60 / RS cells and control HL-60 cells, K562 cells and K562 / ADM cells were extracted by TRIZOL method for total RNA and total protein by RIPA lysate, and real-time fluorescence quantitative RT-PCR method and Western blot were used respectively The expression of arsenic transport related proteins MRP1, MRP2 and ASNA1 was detected by the method. The expression of MRP (MRP1 and MRP2) in HL-60 / RS cells was significantly higher than that in HL-60 cells and K562 / ADM cells; the expression of ASNA1 in HL-60 / RS cells was significantly higher than that in HL-60 cells and K562 / ADM cells, respectively It is 7.34 times of K562 / ADM cells and 2.45 times of HL-60 cells. The expression level of K562 / ADM cells was 0.83 times that of K562 cells. Expression levels of MRP and ASNA1 were consistent with arsenic trioxide sensitivity.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a human leukemia HL-60 cell drug-resistance cell line HL-60/RS cell and a preparation method thereof. The preservation number of the cell line HL-60/RS is CCTCC No. C201430. The preparation method is characterized in that a human leukemia HL-60 cell line is used as a parent cell, adriamycin is used for simulating an internal chemotherapy process, and a gradual long-term intermittent repeated drug concentration impact increasing and continuous induction method is used for establishing the leukemia multidrug-resistance cell line HL-60/RS. The preparation method has the beneficial effects that the leukemia multidrug-resistance cell line HL-60/RS is established by adopting the concentration impact increasing and continuous induction method, and experiments prove that the established drug-resistance cell line has the characteristics of wide drug-resistance spectrum, stable drug resistance and the like; the drug-resistance cell line has high drug resistance and can be used for researching the sensitivity, drug resistance and arsenic resistance of tumor cells to anti-cancer drugs and screening resistance-reversal agents with reliability.

Description

technical field [0001] The invention relates to a drug-resistant human leukemia HL-60 cell strain HL-60 / RS cell and a preparation method thereof. Background technique [0002] Leukemia is one of the most important malignant tumors that endanger young adults. Chemotherapy is still the most important treatment for leukemia. However, drug resistance induced by anticancer drugs in chemotherapy, especially acquired multidrug resistance (multidrug resistance, MDR) phenomenon is the main obstacle hindering the efficacy of leukemia treatment, and it is also an unresolved problem. Arsenic trioxide is an active ingredient of the traditional Chinese medicine arsenic, which has been widely used in the treatment of various types of leukemia and solid tumors, and has achieved good clinical efficacy. Studies have confirmed that arsenic trioxide is not a substrate of drug-resistant protein P-gp and inhibits the expression of P-gp, and does not cause cross-resistance with conventional chemo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/09C12R1/91
Inventor 魏虎来陈静程杰谢蓓易娟王蓓
Owner LANZHOU UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap